Bank Of Montreal Aerie Pharmaceuticals Inc Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$6.37 - $15.23 $2.99 Million - $7.14 Million	468,900 New	468,900 $7.11 Million
Q4 2021 Feb 11, 2022	SELL	$7.02 - $13.33 $1.02 Million - $1.93 Million	-144,951 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.32 - $16.63 $790,611 - $1.16 Million	69,842 Added 92.99%	144,951 $1.66 Million
Q2 2021 Aug 12, 2021	BUY	$15.16 - $18.97 $1.14 Million - $1.42 Million	75,109 New	75,109 $1.36 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.